CBX2 and prostate carcinoma: Such as, Zhou et al. [42] found that CBX2 may function as an oncogene and potential prognostic biomarker in colorectal cancer; CBX3 protein expression was increased in prostate cancer, and Cox survival analysis showed that it was an independent prognostic predictor [43].